INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Flotek Industries, Inc. of Class Action Lawsuit and Upcoming Deadlines

Flotek (FTK) faces a securities class action over alleged fraud/unlawful practices as scrutiny intensifies around its reported $400M natural-gas power project deal with Puerto Rico’s PREPA. After a Wolfpack Research report alleged the deal was canceled/Enchanted Rock’s authorization was revoked, FTK dropped 20.01% to $28.66 on Aug. 17; following Puerto Rico’s Financial Oversight Board vote to direct PREPA to terminate the 10-year contract, the stock fell another 5.72% to $27.02 on Aug. 18. The article frames the dispute as potentially involving unauthorized signatures and regulatory action, raising near-term uncertainty for the company’s backlog and contract outlook.

Analysis

FTK is moving from a growth/backlog story to a credibility and cash-conversion story. If the PREPA work is effectively impaired, the market should not just haircut revenue; it should re-rate the entire backlog book because one anchor contract can support an outsized multiple in a small-cap name until the market believes it is executable. The second-order risk is working-capital leakage: project mobilization, engineering, and staffing costs often hit before cash collection, so a disputed award can flip from headline backlog to a near-term cash drain within one or two quarters.

The catalyst path is messy but mostly negative over the next 2-6 weeks: formal termination notices, amended disclosures, and any auditor reserve language matter more than the lawsuit itself. Over 1-3 months, the key question is whether management can produce documentation that preserves the consortium economics; absent that, litigation adds settlement/legal expense and likely raises the cost of capital. Over 6-18 months, this should tighten diligence standards across small-cap energy services and municipal-power contracting names, with customers demanding stronger counterparties, higher bonding, and less aggressive backlog recognition.

Contrarian view: the stock may already reflect a harsh scenario, but only if the project can be novated or partially preserved. The market is likely underestimating how binary this is for valuation: either the contract survives in economically usable form, or FTK loses both revenue visibility and narrative support. The main falsifier is a formal reinstatement/amendment plus audited backlog confirmation; without that, rallies are likely technical rather than fundamental.

Key Decisions for Investors

• Short FTK on any relief rally over the next 1-2 weeks; use a bounce toward the high-$20s/around $30 as a better entry than selling weakness, with the thesis invalidated only by a formal contract reinstatement or audited backlog confirmation.
• If listed options are liquid, buy a 1-3 month FTK put spread (for example, 25/20 or 30/20) to express a binary downside view while limiting theta bleed; best payoff if disclosure risk compounds before the October deadline.
• Do not buy the dip in FTK until there is documentary proof the project survives; if management only offers verbal reassurance, treat that as a short-covering setup rather than a long signal.
• Set an alert on FTK for any 8-K, impairment charge, or auditor commentary; those are the real catalysts that can force another leg lower within days, not the pending class action itself.